Insurf vs Isomorphic Labs

Side-by-side comparison of features, pricing, and ratings

Analysis reviewed Live tool data as of 2026-10-09
Cross-checked through our multi-step verification ·
Saved

At a glance

DimensionInsurfIsomorphic Labs
Target IndustryHealth insuranceDrug discovery
Core AI ApplicationCost estimation, prior auth automation, denial appealsProtein-ligand prediction, molecular design
PricingContact salesContact sales (partnership model)
Key InnovationCoverage-decision graph for 12-month true costAlphaFold-based Drug Design Engine
Partnership/DeploymentPilot phase with practices and brokersPharma partnerships (Novartis, J&J)
Recent MilestoneAsk HN discussion on AI evangelists (Jul 2026)Series B funding (May 2026)
Insurf
Insurf

Insurf prices every health plan in your county to the dollar and drafts source-cited prior authorizations and denial appeals.

Visit Website
Isomorphic Labs
Isomorphic Labs

Isomorphic Labs applies generative AI drug discovery to design novel molecules and predict how candidates will perform.

Visit Website
Pricing
Contact Sales
Contact Sales
Plans
—
—
Popularity
3 views
7.5k views
Skill Level
Intermediate
Advanced
API Available
Platforms
Web
—
Categories
🧾 Healthcare Revenue Cycle🏥 Healthcare
🧬 Drug Discovery & Life Sciences
Features
Source-cited prior authorization drafting pulled from patient chart data
Source-cited denial appeal drafting with clinical record citations
Physician attestation and sign-off before final export or recorded submission
Staff-controlled submission through existing payer channels
Deadline tracking on filings with contractual fee credits for misses
Worked-or-explained accountability for every eligible case
Candidate list approval before any case work begins
Managed report separating payer decisions from posted payment
Outcome tracking stored as structured data
Coverage-decision graph linking plan choices, prior auth, and appeals
Denial-risk overlay for specialty practices
Appeal gap analysis built on KFF and CMS data
Inveto intake from denial letters, prior-auth forms, and remittances
Plan filings and formulary ingestion
Payer portal integration for submission and status
Drug Design Engine spanning generative molecule design through lead optimization
Predictive AI models that anticipate how candidate drugs will perform
Generative models for designing novel molecules
Builds on and beyond the Nobel-winning AlphaFold system
End-to-end research collaborations from target identification to lead optimization
Digital biology approach aimed at discovery at digital speed
Named pharma partners include Johnson & Johnson, Novartis and Eli Lilly
Joined the Virtual Biology Initiative to build foundational data for AI disease models
Funder of Biohub's $1.8B initiative to train AI models that predict cell behavior
Bioresilience framework for biological threats and health emergencies
Series B investment round announced May 2026 to scale the Drug Design Engine
Follows a $600M external raise in March 2025
President Max Jaderberg appointed November 2025 to integrate AI and science
Interdisciplinary team of drug discovery experts and ML specialists
Founded by Demis Hassabis, who serves as CEO

Who should pick which

  • Specialty medical practice with high denial rates
    Pick: Insurf

    Inveto automates prior authorization and denial appeals with EHR integration, directly addressing denial rate issues.

  • Health insurance broker seeking cost transparency tools
    Pick: Insurf

    Surely provides 12-month true cost estimates using real drugs and doctors, enabling informed plan recommendations.

  • Pharma R&D executive for large-scale drug discovery
    Pick: Isomorphic Labs

    Isomorphic Labs' Drug Design Engine and AlphaFold-based models accelerate lead optimization through predictive and generative AI, backed by J&J partnership.

  • Patient selecting a health plan during open enrollment
    Pick: Insurf

    Surely's cost estimation gives patients total cost clarity across premiums, deductibles, and drug tiers.

  • Research institution exploring digital biology
    Pick: Isomorphic Labs

    Isomorphic Labs offers advanced AI simulation for protein-ligand interactions, but only via partnership.

Frequently Asked Questions

Can I use Insurf as an individual patient?

Yes, Insurf's Surely product is designed for individuals to estimate plan costs during open enrollment, but requires enrollment support from a broker or practice.

Is Isomorphic Labs open to startups or individual researchers?

No, Isomorphic Labs operates solely through deep pharma collaborations and is not available as a product or API.

Does Insurf integrate with my EHR?

Yes, Inveto reads patient charts from EHRs to automate prior authorization and denial appeals.

How does Isomorphic Labs' Drug Design Engine work?

It combines predictive models for protein-ligand interactions and generative AI to design novel molecules, based on AlphaFold.

What is the pricing model for Insurf?

Pricing is available upon contact; likely per-member or per-claim as it targets practices and brokers.

What pharma companies does Isomorphic Labs partner with?

Isomorphic Labs has collaborations with Novartis and Johnson & Johnson.

Does Insurf handle denial appeals?

Yes, Inveto generates denial appeals with source citations and physician attestation automatically.

Is Isomorphic Labs publicly funded?

No, it is a private company that raised $600M in 2025 and a Series B in 2026.

More Insurf or Isomorphic Labs comparisons

Explore each tool further

Browse these categories

Still deciding? Get the weekly AI tools brief

One email a week — new tools, honest comparisons, no spam.

Last reviewed: July 3, 2026